Diagnostyka S.A. (WSE:DIA)

Diagnostyka Statistics

Total Valuation

Diagnostyka has a market cap or net worth of PLN 6.25 billion. The enterprise value is 7.24 billion.

Market Cap	6.25B
Enterprise Value	7.24B

Important Dates

The next estimated earnings date is Friday, December 5, 2025.

Earnings Date	Dec 5, 2025
Ex-Dividend Date	Jun 3, 2025

Share Statistics

Diagnostyka has 33.76 million shares outstanding.

Current Share Class	33.76M
Shares Outstanding	33.76M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	13.58%
Float	n/a

Valuation Ratios

The trailing PE ratio is 26.04 and the forward PE ratio is 20.44. Diagnostyka's PEG ratio is 0.74.

PE Ratio	26.04
Forward PE	20.44
PS Ratio	2.88
PB Ratio	14.37
P/TBV Ratio	n/a
P/FCF Ratio	16.85
P/OCF Ratio	12.31
PEG Ratio	0.74

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.53, with an EV/FCF ratio of 19.53.

EV / Earnings	30.16
EV / Sales	3.34
EV / EBITDA	13.53
EV / EBIT	20.36
EV / FCF	19.53

Financial Position

The company has a current ratio of 0.75, with a Debt / Equity ratio of 2.35.

Current Ratio	0.75
Quick Ratio	0.65
Debt / Equity	2.35
Debt / EBITDA	1.92
Debt / FCF	2.76
Interest Coverage	5.21

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	25.72%
Revenue Per Employee	276,751
Profits Per Employee	30,635
Employee Count	7,836
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Diagnostyka has paid 68.48 million in taxes.

Income Tax	68.48M
Effective Tax Rate	21.53%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	198.94
200-Day Moving Average	n/a
Relative Strength Index (RSI)	42.86
Average Volume (20 Days)	65,990

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Diagnostyka had revenue of PLN 2.17 billion and earned 240.06 million in profits. Earnings per share was 7.11.

Revenue	2.17B
Gross Profit	1.66B
Operating Income	354.65M
Pretax Income	318.07M
Net Income	240.06M
EBITDA	424.54M
EBIT	354.65M
Earnings Per Share (EPS)	7.11

Balance Sheet

The company has 46.19 million in cash and 1.02 billion in debt, giving a net cash position of -976.94 million or -28.94 per share.

Cash & Cash Equivalents	46.19M
Total Debt	1.02B
Net Cash	-976.94M
Net Cash Per Share	-28.94
Equity (Book Value)	434.90M
Book Value Per Share	12.47
Working Capital	-120.65M

Cash Flow

In the last 12 months, operating cash flow was 507.66 million and capital expenditures -136.83 million, giving a free cash flow of 370.83 million.

Operating Cash Flow	507.66M
Capital Expenditures	-136.83M
Free Cash Flow	370.83M
FCF Per Share	10.99

Margins

Gross margin is 76.61%, with operating and profit margins of 16.35% and 11.07%.

Gross Margin	76.61%
Operating Margin	16.35%
Pretax Margin	14.67%
Profit Margin	11.07%
EBITDA Margin	19.58%
EBIT Margin	16.35%
FCF Margin	17.10%

Dividends & Yields

This stock pays an annual dividend of 3.31, which amounts to a dividend yield of 1.79%.

Dividend Per Share	3.31
Dividend Yield	1.79%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	90.56%
Buyback Yield	n/a
Shareholder Yield	1.79%
Earnings Yield	3.84%
FCF Yield	5.93%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Diagnostyka has an Altman Z-Score of 3.98 and a Piotroski F-Score of 4.

Altman Z-Score	3.98
Piotroski F-Score	4